EcoR1 Capital’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

EcoR1 Capital’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-650,489	Closed	-$9.72M	–	71
2022 Q4	$9.72M	Hold	650,489	–	–	0.3%	40
2022 Q3	$5.35M	Buy	650,489 +3,000	+0.5%	+$23K	0.16%	47
2022 Q2	$4.25M	Buy	+647,489	New	+$3.14M	0.15%	50

EcoR1 Capital's AVEO Position: Q1 2023 in Review

EcoR1 Capital sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 650,489 shares — an estimated $9.72M sold.

EcoR1 Capital first reported a position in AVEO in Q2 2022 and held it in 3 quarters. The position peaked at $9.72M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

EcoR1 Capital reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
EcoR1 Capital sold 650,489 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $9.72M.
EcoR1 Capital first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2022 and held it in 3 quarters.
EcoR1 Capital's AVEO Pharmaceuticals, Inc. position peaked at $9.72M in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on EcoR1 Capital's 13F filing for Q1 2023, filed 15 May 2023.